Medicine
Jantoven 4 mg tablet
Jantoven 4 mg tablet is a prescription medicine containing Warfarin for oral use, marketed by Upsher-Smith Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Warfarin
- Brand
- Jantoven
- Strength
- 4 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 100 blister pack, 1000 tablets
- Marketing authorisation holder
- Upsher-Smith Laboratories
- Manufacturer
- Upsher-Smith Laboratories
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Excursions permitted to 15° to 30°C (59° to 86°F). Protect from light and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B01AA03 Warfarin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 23 February 2010
- Identifiers
- RxCUI 855288, 855292, 855296 +7DailyMed set ID 19a69a72-ac5d-45d5-a94d-a5aaecbe4730NDC 0832-1215Application ANDA040416
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 0832-1215-00 | Upsher-Smith Laboratories | 23 February 2010 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0832-1215-01 | Upsher-Smith Laboratories | 23 February 2010 |
| 1000 tablet in 1 bottle | 0832-1215-10 | Upsher-Smith Laboratories | 23 February 2010 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 8 June 1954 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Warfarin 4 mg tablet.
Other strengths and forms of Warfarin
Clinical summary
Warfarin is a vitamin K antagonist indicated for prophylaxis and treatment of venous thrombosis and its extension, pulmonary embolism (PE). It is available as tablets for oral use. MedsAcross supplies Warfarin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about WarfarinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Jantoven prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Jantoven 4 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.